{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:8028bb9f-7f44-4154-bd59-b0d7fef01817","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T11:28:13.387414+00:00","published_at":"2026-10-17T04:46:35.948617+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:zbof9y4te2vc","event_type":"CFO_CHANGED","effective_at":"2026-03-20","detected_at":"2026-10-17T04:46:35.948617+00:00","subject_ids":["alpha:person:david-kirske","alpha:company:8028bb9f-7f44-4154-bd59-b0d7fef01817"],"caused_claim_ids":["alpha:claim:company:8028bb9f-7f44-4154-bd59-b0d7fef01817:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:13a21d2fa22da7cb571068c3e2f2b4649791ce0c78f1ecb797efd501ca8c924a"],"summary":"David Kirske executive of X4 Pharmaceuticals, Inc, effective 2026-03-20.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:p7bms61otku0o","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:35.948617+00:00","subject_ids":["alpha:person:franoise-de-craecker","alpha:company:8028bb9f-7f44-4154-bd59-b0d7fef01817"],"caused_claim_ids":["alpha:claim:company:8028bb9f-7f44-4154-bd59-b0d7fef01817:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:c5c3aeba0de7620d9e71ae69450be02a0a184ddb806c30e2dd039b4fd8c1dae3"],"summary":"Franoise De Craecker seat on X4 Pharmaceuticals, Inc, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1psywc01yourqk","event_type":"COMMITTEE_CREATED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:35.948617+00:00","subject_ids":["alpha:committee:x4-pharmaceuticals-inc:audit-compensation","alpha:company:8028bb9f-7f44-4154-bd59-b0d7fef01817"],"caused_claim_ids":["alpha:claim:company:8028bb9f-7f44-4154-bd59-b0d7fef01817:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:c5c3aeba0de7620d9e71ae69450be02a0a184ddb806c30e2dd039b4fd8c1dae3"],"summary":"Audit; Compensation committee of X4 Pharmaceuticals, Inc, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1si23eb1809ypt","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:35.948617+00:00","subject_ids":["alpha:person:franoise-de-craecker","alpha:committee:x4-pharmaceuticals-inc:audit-compensation"],"caused_claim_ids":["alpha:claim:company:8028bb9f-7f44-4154-bd59-b0d7fef01817:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:c5c3aeba0de7620d9e71ae69450be02a0a184ddb806c30e2dd039b4fd8c1dae3"],"summary":"Franoise De Craecker member of Audit; Compensation, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:raaizq1trstjo","event_type":"DIRECTOR_APPOINTED","effective_at":"2019-01-01","detected_at":"2026-10-17T04:46:35.948617+00:00","subject_ids":["alpha:person:murray-w-stewart-m-d","alpha:company:8028bb9f-7f44-4154-bd59-b0d7fef01817"],"caused_claim_ids":["alpha:claim:company:8028bb9f-7f44-4154-bd59-b0d7fef01817:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:c5c3aeba0de7620d9e71ae69450be02a0a184ddb806c30e2dd039b4fd8c1dae3"],"summary":"Murray W. Stewart, M.D. seat on X4 Pharmaceuticals, Inc, effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:c4wssd1t9um0r","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:46:35.948617+00:00","subject_ids":["alpha:person:gary-j-bridger-ph-d","alpha:company:8028bb9f-7f44-4154-bd59-b0d7fef01817"],"caused_claim_ids":["alpha:claim:company:8028bb9f-7f44-4154-bd59-b0d7fef01817:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:c5c3aeba0de7620d9e71ae69450be02a0a184ddb806c30e2dd039b4fd8c1dae3"],"summary":"Gary J. Bridger, Ph.D. seat on X4 Pharmaceuticals, Inc, effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1bfrra010giyao","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:46:35.948617+00:00","subject_ids":["alpha:person:michael-s-wyzga","alpha:company:8028bb9f-7f44-4154-bd59-b0d7fef01817"],"caused_claim_ids":["alpha:claim:company:8028bb9f-7f44-4154-bd59-b0d7fef01817:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:c5c3aeba0de7620d9e71ae69450be02a0a184ddb806c30e2dd039b4fd8c1dae3"],"summary":"Michael S. Wyzga seat on X4 Pharmaceuticals, Inc, effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:z0yfig1784tkg","event_type":"COMMITTEE_CREATED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:46:35.948617+00:00","subject_ids":["alpha:committee:x4-pharmaceuticals-inc:audit-chair-nominating-and-governance-chair","alpha:company:8028bb9f-7f44-4154-bd59-b0d7fef01817"],"caused_claim_ids":["alpha:claim:company:8028bb9f-7f44-4154-bd59-b0d7fef01817:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:c5c3aeba0de7620d9e71ae69450be02a0a184ddb806c30e2dd039b4fd8c1dae3"],"summary":"Audit · Chair; Nominating and Governance · Chair committee of X4 Pharmaceuticals, Inc, effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ft58w01xuup1m","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:46:35.948617+00:00","subject_ids":["alpha:person:michael-s-wyzga","alpha:committee:x4-pharmaceuticals-inc:audit-chair-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:8028bb9f-7f44-4154-bd59-b0d7fef01817:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:c5c3aeba0de7620d9e71ae69450be02a0a184ddb806c30e2dd039b4fd8c1dae3"],"summary":"Michael S. Wyzga member of Audit · Chair; Nominating and Governance · Chair, effective 2018-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:8028bb9f-7f44-4154-bd59-b0d7fef01817:leadership_role:6","subject_id":"alpha:company:8028bb9f-7f44-4154-bd59-b0d7fef01817","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:franoise-de-craecker","object_label":"Franoise De Craecker","object_source_name_forms":[],"value":"Franoise De Craecker: Director, Audit; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:franoise-de-craecker","name":"Franoise De Craecker"},"title":"Director","role_category":"director","committee":"Audit; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:35.948617+00:00","sources":[{"id":"alpha:projection-evidence:document:c5c3aeba0de7620d9e71ae69450be02a0a184ddb806c30e2dd039b4fd8c1dae3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"X4 Pharmaceuticals, Inc DEF 14A 2026-03-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","source_date":"2026-03-20","retrieved_at":"2026-04-25T00:23:00.668+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-20","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:35.948617+00:00","reviewed_at":"2026-10-17T04:46:35.948617+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8028bb9f-7f44-4154-bd59-b0d7fef01817:leadership_role:7","subject_id":"alpha:company:8028bb9f-7f44-4154-bd59-b0d7fef01817","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:gary-j-bridger-ph-d","object_label":"Gary J. Bridger, Ph.D.","object_source_name_forms":[],"value":"Gary J. Bridger, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:gary-j-bridger-ph-d","name":"Gary J. Bridger, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:35.948617+00:00","sources":[{"id":"alpha:projection-evidence:document:c5c3aeba0de7620d9e71ae69450be02a0a184ddb806c30e2dd039b4fd8c1dae3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"X4 Pharmaceuticals, Inc DEF 14A 2026-03-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","source_date":"2026-03-20","retrieved_at":"2026-04-25T00:23:00.668+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-20","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:35.948617+00:00","reviewed_at":"2026-10-17T04:46:35.948617+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8028bb9f-7f44-4154-bd59-b0d7fef01817:leadership_role:8","subject_id":"alpha:company:8028bb9f-7f44-4154-bd59-b0d7fef01817","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michael-s-wyzga","object_label":"Michael S. Wyzga","object_source_name_forms":[],"value":"Michael S. Wyzga: Director, Audit · Chair; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:michael-s-wyzga","name":"Michael S. Wyzga"},"title":"Director","role_category":"director","committee":"Audit · Chair; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:35.948617+00:00","sources":[{"id":"alpha:projection-evidence:document:c5c3aeba0de7620d9e71ae69450be02a0a184ddb806c30e2dd039b4fd8c1dae3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"X4 Pharmaceuticals, Inc DEF 14A 2026-03-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","source_date":"2026-03-20","retrieved_at":"2026-04-25T00:23:00.668+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-20","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:35.948617+00:00","reviewed_at":"2026-10-17T04:46:35.948617+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8028bb9f-7f44-4154-bd59-b0d7fef01817:leadership_role:9","subject_id":"alpha:company:8028bb9f-7f44-4154-bd59-b0d7fef01817","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:murray-w-stewart-m-d","object_label":"Murray W. Stewart, M.D.","object_source_name_forms":[],"value":"Murray W. Stewart, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:murray-w-stewart-m-d","name":"Murray W. Stewart, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:35.948617+00:00","sources":[{"id":"alpha:projection-evidence:document:c5c3aeba0de7620d9e71ae69450be02a0a184ddb806c30e2dd039b4fd8c1dae3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"X4 Pharmaceuticals, Inc DEF 14A 2026-03-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","source_date":"2026-03-20","retrieved_at":"2026-04-25T00:23:00.668+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-20","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:35.948617+00:00","reviewed_at":"2026-10-17T04:46:35.948617+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8028bb9f-7f44-4154-bd59-b0d7fef01817:leadership_role:10","subject_id":"alpha:company:8028bb9f-7f44-4154-bd59-b0d7fef01817","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:david-kirske","object_label":"David Kirske","object_source_name_forms":[],"value":"David Kirske: Chief Financial Officer, Treasurer and Corporate Secretary","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:david-kirske","name":"David Kirske"},"title":"Chief Financial Officer, Treasurer and Corporate Secretary","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-20","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-20","valid_to":null,"recorded_at":"2026-10-17T04:46:35.948617+00:00","sources":[{"id":"alpha:projection-evidence:document:13a21d2fa22da7cb571068c3e2f2b4649791ce0c78f1ecb797efd501ca8c924a","identity_scope":"source_document_reference","source_type":"sec_filing","title":"XFOR DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","source_date":"2026-03-20T00:00:00+00:00","retrieved_at":"2026-05-16T10:23:36.52142+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-20T00:00:00+00:00","effective_from":"2026-03-20","effective_until":null,"observed_at":"2026-10-17T04:46:35.948617+00:00","reviewed_at":"2026-10-17T04:46:35.948617+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:c5c3aeba0de7620d9e71ae69450be02a0a184ddb806c30e2dd039b4fd8c1dae3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"X4 Pharmaceuticals, Inc DEF 14A 2026-03-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","source_date":"2026-03-20","retrieved_at":"2026-04-25T00:23:00.668+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:13a21d2fa22da7cb571068c3e2f2b4649791ce0c78f1ecb797efd501ca8c924a","identity_scope":"source_document_reference","source_type":"sec_filing","title":"XFOR DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","source_date":"2026-03-20T00:00:00+00:00","retrieved_at":"2026-05-16T10:23:36.52142+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.827,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.847,"cross_source_agreement":0.75,"temporal_completeness":0.5},"diagnostics":{"published_claims":17,"factual_claims":17,"claims_with_linked_evidence":17,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":10,"temporal_claims_with_valid_from":5,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:46:35.948617+00:00","observed_at":"2026-10-17T04:46:35.948617+00:00","reviewed_at":"2026-10-17T04:46:35.948617+00:00","verified_at":"2026-10-17T04:46:35.948617+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":17,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/x4-pharmaceuticals-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/x4-pharmaceuticals-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}